Introduction.
SinoMab BioScience Limited is dedicated to the research, development, manufacturing, and commercialization of therapeutics for the treatment of immunological diseases. Headquartered in Hong Kong with its R&D base in Hong Kong and production base in China, SinoMab is the first Hong Kong home-grown biopharmaceutical company listed on the Hong Kong Stock Exchange.